When DILI patients were ANA-positive, there were no statistically significant differences in ALB, TC, LDL, Hb, PT, INR, ANA titers, and ANA fluorescence patterns compared to AIH patients, suggesting that the differences between the 2 diseases are diminished, complicating differential diagnosis. This evidence concerns the gene BTG3 and autoimmune hepatitis.